IL6 and COVID-19: In a retrospective study of 120 Chinese patients with pre-existing diabetes and confirmed and unconfirmed but clinically diagnosed COVID-19, a significantly lower increase in interleukin-6 was observed in metformin users prior to admission, compared to non-users (n = 77)20.